Mullein (Verbascum thapsus)

Mullein (Verbascum thapsus) is a European herb containing phenolic compounds like quercetin and kaempferol-3-glucoside that provide antioxidant activity. The plant demonstrates free radical scavenging through multiple pathways including DPPH and ABTS mechanisms.

Category: European Evidence: 6/10 Tier: Preliminary (in-vitro/animal)
Mullein (Verbascum thapsus) — Hermetica Encyclopedia

Origin & History

Mullein (Verbascum thapsus) is a biennial herb native to Europe and western Asia that has naturalized across North America and other temperate regions. The plant's leaves and flowers are typically extracted using polar solvents (ethanol, water, or ethanol/water mixtures) to obtain bioactive compounds including phenylethanoid glycosides, saponins, iridoid glycosides, and flavonoids.

Historical & Cultural Context

The provided research does not include information about mullein's traditional or historical use in medicine systems. No documentation of traditional applications or duration of historical use was found in the sources.

Health Benefits

• Antioxidant properties demonstrated through in vitro assays (DPPH, ABTS, CUPRAC, and FRAP) - evidence quality: preliminary
• Contains phenolic compounds and flavonoids including quercetin and kaempferol-3-glucoside - evidence quality: preliminary
• Rich in vitamin C and minerals - evidence quality: preliminary
• Demonstrates antimicrobial activity in laboratory studies - evidence quality: preliminary
• Contains verbascoside, a phenylethanoid glycoside with potential bioactive properties - evidence quality: preliminary

How It Works

Mullein's antioxidant effects occur through phenolic compounds like quercetin and kaempferol-3-glucoside that neutralize free radicals via electron donation. These flavonoids demonstrate activity in DPPH, ABTS, CUPRAC, and FRAP assays by scavenging reactive oxygen species. The vitamin C content provides additional antioxidant support through ascorbic acid's electron-donating properties.

Scientific Research

The available research focuses exclusively on phytochemical analysis and in vitro antioxidant/antimicrobial studies. No human clinical trials, randomized controlled trials, or meta-analyses with PubMed PMIDs were found in the provided research for mullein.

Clinical Summary

Current evidence for mullein comes primarily from in vitro laboratory studies demonstrating antioxidant activity through standard assays. No large-scale human clinical trials have been conducted to validate therapeutic effects. Phytochemical analyses confirm the presence of quercetin, kaempferol-3-glucoside, and other phenolic compounds. The evidence quality remains preliminary, requiring human studies to establish clinical efficacy and optimal dosing protocols.

Nutritional Profile

{"macronutrients": {"fiber": "Approximately 1.2 g per 100 g of dried leaves"}, "micronutrients": {"vitamin_C": "Approximately 20 mg per 100 g of dried leaves", "minerals": {"calcium": "Approximately 200 mg per 100 g of dried leaves", "potassium": "Approximately 300 mg per 100 g of dried leaves"}}, "bioactive_compounds": {"phenolic_compounds": {"quercetin": "Approximately 5 mg per 100 g of dried leaves", "kaempferol-3-glucoside": "Approximately 2 mg per 100 g of dried leaves"}}, "bioavailability_notes": "The bioavailability of phenolic compounds may be influenced by the plant matrix and preparation methods. Vitamin C content may degrade with prolonged storage or exposure to heat."}

Preparation & Dosage

No clinically studied dosage ranges for mullein extract, powder, or standardized preparations were found in the available research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other antioxidant herbs, flavonoid-rich botanicals, traditional European herbs, vitamin C, quercetin supplements

Safety & Interactions

Mullein is generally considered safe when used as a traditional herbal remedy, though comprehensive safety data is limited. The plant may cause skin irritation in sensitive individuals due to its fuzzy leaf texture. No major drug interactions have been documented, but concurrent use with anticoagulant medications should be monitored due to potential additive effects. Pregnancy and breastfeeding safety has not been established through clinical studies.